Research Library

BPC-157 is a synthetic pentadecapeptide whose sequence derives from a protective protein found in gastric juice. It is one of the most widely studied peptides in preclinical tissue-repair research, notable for its stability in acidic conditions.

TB-500 is a synthetic peptide corresponding to an active region of Thymosin Beta-4, a naturally occurring actin-binding protein. It is studied in preclinical models of cell migration, angiogenesis, and tissue repair.

Semax is a synthetic heptapeptide derived from a fragment of the ACTH hormone. It is studied in preclinical neuroscience research, particularly for its reported interactions with neurotrophic signaling in rodent models.

A combination of two of the most-studied repair-associated research peptides — BPC-157 and TB-500 — supplied together for laboratory research into tissue-repair pathways.

A pairing of a GHRH analog (CJC-1295 without DAC) and a selective ghrelin-receptor agonist (Ipamorelin) — two growth-hormone-secretagogue research peptides commonly studied together.

GHK-Cu is a naturally occurring copper-binding tripeptide widely studied in skin, tissue-remodeling, and gene-expression research, and used as a cosmetic ingredient.

The GLOW blend combines GHK-Cu, BPC-157, and TB-500 — three research peptides studied in tissue-remodeling and repair contexts — in a single research preparation.

Semaglutide is a GLP-1 receptor agonist peptide extensively studied in metabolic and incretin-signaling research.

GLP-2 TZ is a dual-incretin research peptide studied for agonism at both the GIP and GLP-1 receptors — the dual-agonist (tirzepatide-class) mechanism used in metabolic research.

GLP-3 RT is a triple-incretin research peptide studied for agonism at the GIP, GLP-1, and glucagon receptors — the triple-agonist (retatrutide-class) mechanism used in metabolic research.

Tesamorelin is a stabilized synthetic analog of growth-hormone-releasing hormone (GHRH), studied in research on the growth-hormone / IGF-1 axis.